A Retrospective Study of Sintered Porous-Surfaced Dental Implants in Restoring the Edentulous Posterior Mandible: Up to 9 Years of Functioning

Abstract

The cumulative survival rate of the porous-surfaced implants placed in the edentulous posterior mandibles was 97.5%. Short porous-surfaced implants showed satisfactory results after a maximum of 9 years of functioning in the edentulous posterior mandibles.

Should the restoration of adjacent implants be splinted or nonsplinted? A systematic review and meta-analysis

“…Applying the inclusion/exclusion criteria to the titles and abstracts of the selected comparative studies left 20 studies (k=0.95). 4,5,[19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36] Upon reading the full texts, 1 study 35 was excluded because it did not report information about crestal bone loss, implant survival, or prosthetic complications of splinted and nonsplinted implants. Details of the search strategy are presented in a flow diagram (Fig.…”

“…A total of 19 studies 4,5,[19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34]36 were selected for qualitative and quantitative analyses. One was an RCT, 4 7 were prospective clinical trials, 5,19,21,[24][25][26]34 and 11 were retrospective studies.…”

Technical and Biological Complications Related to Crown to Implant Ratio

“…In the study by Sohn et al, 77 there were no failed cases when the C/I ratio was ,1.0. The mean follow-up observation period was at least 48 months, and the cumulative success rates reported by the various authors were between 95% and 100%.…”

“…In fact, some articles evaluated the anatomical C/I (aC/ I) ratio, 77,82 whereas others evaluated the clinical C/I ratio (cC/I) (Fig. In fact, some articles evaluated the anatomical C/I (aC/ I) ratio, 77,82 whereas others evaluated the clinical C/I ratio (cC/I) (Fig.…”

A 5-year prospective clinical study of Neobiotech implants for partially edentulous patients

“…This result is comparable with CSR results of previous studies of widely used titanium implants in Korean population with survival rate ranges from 95.4 -98.9% and follow up period from 5 to 9 years. 12,14,[23][24][25] Furthermore, 5 and 10-year retrospective clinical study of Implantium implants system (Dentium, Seoul, South Korea) and 7 years of Osstem implants (Osstem Implant Co., Ltd., Busan, Korea) reported a CSR of 97.27%, 97.9% and 95.37% respectively.…”